{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:44:32Z","timestamp":1790016272096,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Taisho Toyama Pharmaceutical Co., Ltd."},{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eisai Co., Ltd."},{"name":"Daiichi-Sankyo Co., Ltd."},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi & Co. Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Meiji Seika Pharma Co., Ltd."},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jiac.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T09:15:16Z","timestamp":1541236516000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital"],"prefix":"10.1016","volume":"25","author":[{"given":"Toru","family":"Sakagami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eio","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritomo","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kaeriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Mitsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-8767","authenticated-orcid":false,"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.10.007_bib1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2018.10.007_bib2","first-page":"1199","article-title":"Treatment of invasive candidiasis in the elderly: a review","volume":"8","author":"Flevari","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jiac.2018.10.007_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/JCM.02566-12","article-title":"Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011","volume":"51","author":"Asmundsdottir","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2018.10.007_bib4","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.007_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhin.2010.01.022","article-title":"Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008","volume":"76","author":"Playford","year":"2010","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jiac.2018.10.007_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1471-2334-14-241","article-title":"Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai","volume":"14","author":"Yang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.007_bib7","first-page":"128","article-title":"Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2005","volume":"19","author":"Yamaguchi","year":"2009","journal-title":"J\u00a0Jpn Soc Clin Microbiol"},{"key":"10.1016\/j.jiac.2018.10.007_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/2352633501804010001","article-title":"Antifungal susceptibility pattern of Candida albicans in human infections","volume":"4","author":"Zaidi","year":"2018","journal-title":"Open Biol Sci J"},{"key":"10.1016\/j.jiac.2018.10.007_bib9","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.007_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.007_bib11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/QCO.0000000000000215","article-title":"Clinical perspectives on echinocandin resistance among Candida species","volume":"28","author":"Shields","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.007_bib12","first-page":"11","article-title":"Candida glabrata biofilms: how far have we come?","volume":"3","author":"Rodrigues","year":"2017","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.jiac.2018.10.007_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.007_bib14","doi-asserted-by":"crossref","first-page":"e17589","DOI":"10.1371\/journal.pone.0017589","article-title":"Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata","volume":"6","author":"Ferrari","year":"2011","journal-title":"PloS One"},{"issue":"Suppl 3","key":"10.1016\/j.jiac.2018.10.007_bib15","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1093\/infdis\/jix130","article-title":"Novel agents and drug targets to meet the challenges of resistant fungi","volume":"216","author":"McCarthy","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.007_bib16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.01159-07","article-title":"In\u00a0vitro and in\u00a0vivo antifungal activities of T-2307, a novel arylamidine","volume":"52","author":"Mitsuyama","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib17","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd ed. M27-A3","year":"2008"},{"key":"10.1016\/j.jiac.2018.10.007_bib18","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts, 4th informational supplement. M27-S4","year":"2012"},{"key":"10.1016\/j.jiac.2018.10.007_bib19","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/jac\/dks112","article-title":"Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression","volume":"67","author":"Niimi","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib21","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/AAC.05954-11","article-title":"T-2307 causes collapse of mitochondrial membrane potential in yeast","volume":"56","author":"Shibata","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib22","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3314\/mmj.17-00014","article-title":"National Trends in the distribution of Candida species causing candidemia in Japan from 2003 to 2014","volume":"59","author":"Kakeya","year":"2018","journal-title":"Med Mycol J"},{"key":"10.1016\/j.jiac.2018.10.007_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/dkh053","article-title":"National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin","volume":"53","author":"Takakura","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/JCM.01398-10","article-title":"Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)","volume":"49","author":"Pfaller","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2018.10.007_bib25","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3314\/mmj.55.E1","article-title":"Antifungal susceptibility of Candida isolates at one institution","volume":"55","author":"Katsuragi","year":"2014","journal-title":"Med Mycol J"},{"key":"10.1016\/j.jiac.2018.10.007_bib26","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1128\/AAC.00355-10","article-title":"T-2307 shows efficacy in a murine model of Candida glabrata infection despite in\u00a0vitro trailing growth phenomena","volume":"54","author":"Yamada","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/jac\/dkv398","article-title":"The novel arylamidine T-2307 demonstrates in\u00a0vitro and in\u00a0vivo activity against echinocandin-resistant Candida glabrata","volume":"71","author":"Wiederhold","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib28","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1128\/AAC.04228-14","article-title":"The novel arylamidine T-2307 maintains in\u00a0vitro and in\u00a0vivo activity against echinocandin-resistant Candida albicans","volume":"59","author":"Wiederhold","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.01674-13","article-title":"Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib30","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1128\/AAC.03255-14","article-title":"Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance","volume":"58","author":"Pham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00591-18","article-title":"Clonal spread in Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12-year single-center study in Belgium","volume":"62","author":"Goemaere","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.007_bib32","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata","volume":"50","author":"Pfaller","year":"2012","journal-title":"J\u00a0Clin Microbiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:58:04Z","timestamp":1761159484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18303994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1341321X18303994"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.10.007","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}